Literature DB >> 34155202

Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly.

Georgios N Hatzopoulos1, Tim Kükenshöner1, Niccolò Banterle1, Tatiana Favez1, Isabelle Flückiger1,2, Virginie Hamel1,3, Santiago Andany4, Georg E Fantner4, Oliver Hantschel5,6, Pierre Gönczy7.   

Abstract

Centrioles are evolutionarily conserved multi-protein organelles essential for forming cilia and centrosomes. Centriole biogenesis begins with self-assembly of SAS-6 proteins into 9-fold symmetrical ring polymers, which then stack into a cartwheel that scaffolds organelle formation. The importance of this architecture has been difficult to decipher notably because of the lack of precise tools to modulate the underlying assembly reaction. Here, we developed monobodies against Chlamydomonas reinhardtii SAS-6, characterizing three in detail with X-ray crystallography, atomic force microscopy and cryo-electron microscopy. This revealed distinct monobody-target interaction modes, as well as specific consequences on ring assembly and stacking. Of particular interest, monobody MBCRS6-15 induces a conformational change in CrSAS-6, resulting in the formation of a helix instead of a ring. Furthermore, we show that this alteration impairs centriole biogenesis in human cells. Overall, our findings identify monobodies as powerful molecular levers to alter the architecture of multi-protein complexes and tune centriole assembly.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34155202     DOI: 10.1038/s41467-021-23897-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  47 in total

1.  SAS-6 is a cartwheel protein that establishes the 9-fold symmetry of the centriole.

Authors:  Yuki Nakazawa; Madoka Hiraki; Ritsu Kamiya; Masafumi Hirono
Journal:  Curr Biol       Date:  2007-12-18       Impact factor: 10.834

2.  DSAS-6 organizes a tube-like centriole precursor, and its absence suggests modularity in centriole assembly.

Authors:  Ana Rodrigues-Martins; Mónica Bettencourt-Dias; Maria Riparbelli; Cláudia Ferreira; Inês Ferreira; Giuliano Callaini; David M Glover
Journal:  Curr Biol       Date:  2007-08-09       Impact factor: 10.834

3.  [Incidence of valvular heart diseases in patients with systolic murmur found during onset of acute rheumatic fever].

Authors:  T Kaszubowa; J Nowicka
Journal:  Pediatr Pol       Date:  1973-11

4.  Contact dermatitis due to the constituents of Hibiscrub.

Authors:  D L Roberts; R Summerly; J P Byrne
Journal:  Contact Dermatitis       Date:  1981-11       Impact factor: 6.600

5.  SAS-6 defines a protein family required for centrosome duplication in C. elegans and in human cells.

Authors:  Sebastian Leidel; Marie Delattre; Lorenzo Cerutti; Karine Baumer; Pierre Gönczy
Journal:  Nat Cell Biol       Date:  2005-02       Impact factor: 28.824

Review 6.  Centrosomal and Non-centrosomal Functions Emerged through Eliminating Centrosomes.

Authors:  Yutaka Takeda; Kanako Kuroki; Takumi Chinen; Daiju Kitagawa
Journal:  Cell Struct Funct       Date:  2020-04-09       Impact factor: 2.212

7.  Electrostatic interactions between cytochrome P-450 LM2 and NADPH-cytochrome P-450 reductase.

Authors:  R Bernhardt; R Kraft; A Otto; K Ruckpaul
Journal:  Biomed Biochim Acta       Date:  1988

8.  Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Authors:  Ryan A Denu; Maria Shabbir; Minakshi Nihal; Chandra K Singh; B Jack Longley; Mark E Burkard; Nihal Ahmad
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

9.  Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

Authors:  Zhong Y Yeow; Bramwell G Lambrus; Rebecca Marlow; Kevin H Zhan; Mary-Anne Durin; Lauren T Evans; Phillip M Scott; Thao Phan; Elizabeth Park; Lorena A Ruiz; Daniela Moralli; Eleanor G Knight; Luned M Badder; Daniela Novo; Syed Haider; Catherine M Green; Andrew N J Tutt; Christopher J Lord; J Ross Chapman; Andrew J Holland
Journal:  Nature       Date:  2020-09-09       Impact factor: 49.962

10.  TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.

Authors:  Franz Meitinger; Midori Ohta; Kian-Yong Lee; Sadanori Watanabe; Robert L Davis; John V Anzola; Ruth Kabeche; David A Jenkins; Andrew K Shiau; Arshad Desai; Karen Oegema
Journal:  Nature       Date:  2020-09-09       Impact factor: 49.962

View more
  1 in total

1.  Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast Cancers.

Authors:  Xuelin Xia; Xiaoyuan Yang; Wei Huang; Xiaoxia Xia; Deyue Yan
Journal:  Nanomicro Lett       Date:  2021-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.